Showing results (221-230 of 258) with videos related to
Sort By:
Pageof 26
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 21, 2016
How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory ToxicologyClemens Wittwehr, Hristo Aladjov, Gerald Ankley, et al.Regulatory Toxicology and Pharmacology : RTP|September 14, 2022
Use of New Approach Methodologies (NAMs) in regulatory decisions for chemical safety: Report from an EPAA Deep Dive WorkshopCarl Westmoreland, Hans J Bender, John E Doe, et al.Plos One|November 9, 2013
Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosisNadia Sivova, David Launay, Lidwine Wémeau-Stervinou, et al.RMD Open|November 21, 2024
Impact of autoantibody status on stratifying the risk of organ involvement and mortality in SSc: experience from a multicentre French cohort of 1605 patientsKevin Didier, Vincent Sobanski, Ailsa Robbins, et al.Frontiers in Neuroengineering|May 13, 2011
Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicalsA Novellino, Bibiana Scelfo, T Palosaari, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|March 12, 2011
German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificityH Christiansen, B Kis, O Hirsch, et al.Journal of Attention Disorders|March 24, 2012
German validation of the conners adult ADHD rating scale-self-report: confirmation of factor structure in a large sample of participants with ADHDHanna Christiansen, Oliver Hirsch, Alexandra Philipsen, et al.SAR and QSAR in Environmental Research|February 20, 2016
QSAR Toolbox - workflow and major functionalitiesS D Dimitrov, R Diderich, T Sobanski, et al.Pharmacopsychiatry|October 5, 2020
Safety Profile of Methylphenidate Under Long-Term Treatment in Adult ADHD Patients - Results of the COMPAS StudyBernhard Kis, Caroline Lücke, Mona Abdel-Hamid, et al.Journal of Translational Autoimmunity|January 23, 2023
COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infectionCloé Comarmond, Elodie Drumez, Julien Labreuche, et al.Pageof 26